Amgen boosts outlook on positive first-quarter results
By Staff Report / Tuesday, April 21st, 2015 / Earnings, East Ventura County, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Amgen boosts outlook on positive first-quarter results
On the strength on the results, the company raised its full-year earnings per share guidance to between $9.35 and $9.65 from its previous forecast of $9.05 to $9.40.
Read More →FDA approves Amgen heart drug
By Staff Report / Wednesday, April 15th, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on FDA approves Amgen heart drug
The drug is the first chronic heart failure medication approved by the FDA in nearly a decade.
Read More →Amgen alum speeds toward OK for chin drug
By Erika Martin / Friday, April 10th, 2015 / Central Coast Health Watch, East Ventura County, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen alum speeds toward OK for chin drug
Known as ATX-101, the facial injection for the treatment of double chins has been recommended for approval by an FDA advisory committee.
Read More →Amgen touts positive results with new heart health drug
By Erika Martin / Friday, March 20th, 2015 / Central Coast Health Watch, East Ventura County, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen touts positive results with new heart health drug
If approved, it will be the Thousand Oaks-based biotech giant’s first new drug on the market since the FDA’s landmark approval of the first-ever biosimilar drug on the American market.
Read More →Amgen braces for battle over biosimilars
By Erika Martin / Friday, March 13th, 2015 / East Ventura County, Latest news, Technology, Top Stories / Comments Off on Amgen braces for battle over biosimilars
On March 9, a company memo announced its plans to shutter San Francisco facilities once belonging to Onyx Pharmaceuticals and lay off 300 employees there.
Read More →Region wins as Amgen shuffles jobs
By Staff Report / Tuesday, March 10th, 2015 / Latest news, Technology, Top Stories / Comments Off on Region wins as Amgen shuffles jobs
In a company memo circulated yesterday, Amgen CEO Robert Bradway said the firm will begin reconsolidating oncology operations into its Thousand Oaks headquarters.
Read More →Amgen’s portfolio threatened as FDA paves path for lower-cost drugs
By Staff Report / Friday, March 6th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen’s portfolio threatened as FDA paves path for lower-cost drugs
Zarxio, the first biopharmaceutical copycat approved in the U.S., will pave the way for lower-cost alternatives to existing treatments.
Read More →Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue
